Burlington, Vermont

Burlington has emerged as a premier life sciences hub in the Northeast, blending world-class academic research with a thriving biotechnology and medical device ecosystem.

At the center of this innovation is the University of Vermont (UVM) and its Larner College of Medicine, which serves as a cornerstone for academic research and clinical excellence.

The region is best known for its focus on rural healthcare innovation, leveraging the UVM Center for Biomedical Innovation to develop cutting-edge medical devices and digital health solutions.

The recent opening of the BioLabs Innovation Center at UVM provides early-stage biotech startups with state-of-the-art shared wet lab space and specialized equipment to accelerate drug discovery and mRNA production.

Burlington’s private sector is anchored by industry leaders, fostering a robust biopharmaceutical and diagnostics manufacturing corridor.

Strategic partnerships between the UVM Health Network and local entrepreneurs facilitate rapid clinical trial recruitment and real-world evidence gathering.

The ecosystem also benefits from a high concentration of contract research organizations (CROs) and biologics experts, making it a competitive destination for venture capital investment.

With a unique emphasis on precision medicine and immunology, Burlington is redefining how small-market cities contribute to global healthcare breakthroughs.

This collaborative environment ensures that life sciences companies in Vermont can scale from concept to commercialization while maintaining a superior quality of life.